SOX9 and gastric cancer: A significant positive correlation between overexpressed SOX9 and poorer overall survival (OS) was observed in the GC patients (HR = 1.40, 95% CI: 1.14–1.72; P = .001) in the random effects model with a significant heterogeneity (I2 = 52%, P = .04).